According to Aura Biosciences's latest financial reports the company has HK$1.35 Billion in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2022-12-31 | HK$1.47 B | 26.92% |
2021-12-31 | HK$1.16 B | 762.05% |
2020-12-31 | HK$0.13 B | -46.65% |
2019-12-31 | HK$0.25 B |